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Abstract
Objectives—Given the conflicting definitions of “generalized osteoarthritis” (GOA) in the
literature, we performed a systematic review of GOA definitions, risk factors, and outcomes.
Methods—We searched the Medline literature with terms: osteoarthritis, generalized,
polyarticular, multiple joint, and multi-joint, to obtain articles related to GOA, following
evidence-based guidelines. Titles and abstracts of 948 articles were reviewed, with full text review
of 108. Data were extracted based on pre-specified criteria for 74 articles plus 24 identified
through bibliographic review (total=98).
Results—Twenty-four large cohorts (n~30,000) were represented along with numerous clinical
series (n~9000), across 22 countries and 60 years (1952–2012). No less than 15 definitions of
GOA were given in 30 studies with a stated GOA definition; at least 6 groups used a summed
score of joints or radiographic grades. Prevalence estimates based on these GOA definitions were
1–80%, although most were 5–25%. Increased risk and progression of GOA was associated with
age, female sex, and genetic/familial factors. Associations with increased body mass index or bone
mineral density were not consistent. One study estimated the heritability of GOA at 42%.
Collagen biomarker levels increased with number of involved joints. Increased OA burden was
associated with increased mortality and disability, poorer health and function.
© 2013 Elsevier Inc. All rights reserved.
Corresponding Author: Amanda E. Nelson MD MSCR, University of North Carolina at Chapel Hill, Thurston Arthritis Research
Center, Doc J. Thurston Building, Campus Box 7280, Chapel Hill, NC 27599-7280, Phone: (919)966-0553, fax: (919)966-1739,
aenelson@med.unc.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
COMPETING INTERESTS: The authors declare no competing interest in relation to this work.
NIH Public Access
Author Manuscript
Semin Arthritis Rheum. Author manuscript; available in PMC 2015 June 01.
Published in final edited form as:






















Conclusion—While there remains no standard definition of GOA, this term is commonly used.
The impact on health may be greater when OA is in more than one joint. A descriptive term, such
as multi-joint or polyarticular OA, designating OA of multiple joints or joint groups, is
recommended.
INTRODUCTION
Generalized osteoarthritis (GOA) is a term that is widely used in the literature in an attempt
to describe the often polyarticular nature of osteoarthritis (OA). Polyarticular involvement in
OA was described as early as the mid-1800’s (although this report also included descriptions
of inflammatory arthritis)(1), followed by a description of “chronic degenerative
polyarthritis” of menopause in 1926(2), and the first clearly recognizable description of
GOA in 1952(3). Unfortunately, to date, there is no clear, consistent definition for what
actually constitutes GOA, and numerous alternative terms are used (e.g. polyarticular OA,
multijoint or multiple joint OA, or lists of affected joints). One reference often cited as a
definition of GOA (Lawrence 1969, (4)) actually explores two definitions (3 or more, and 5
or more joints). Although it remains clear that multiple joints are commonly involved in OA,
the definition of the term GOA itself remains vague at best, and misleading at worst, since
this term cannot be understood in the absence of a clearly stated definition by the authors,
which may or may not be provided.
To examine the strengths and limitations of current definitions of GOA and the associations
between GOA and risk factors and outcomes, we reviewed the literature reporting on
multiple joint involvement in OA since 1946 to form a systematic summary of the work to
date. Through this effort, we hope to identify difficulties and weaknesses with the current
body of literature, and to suggest ways to improve the study of polyarticular involvement in
OA, which we view as an important consideration in ongoing research which so often
focuses on single joint sites in isolation.
METHODS
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines, and with the assistance of a professional research librarian, we
performed a Medline (1946-present) search first on March 23, 2011 and updated on
September 25, 2012 for articles related to GOA (osteoarthritis, osteoarthrosis, degenerative
joint disease, generalized, polyarticular, global, nodal, multiple joint, multi-joint, etc.) and
published in a clinical journal, limited to English language articles in human adults (age 19
years and up, see Table 1 for full search details). Given the lack of standardized
terminology, we limited our search to Medline to obtain the most relevant articles. Initial
inclusion criteria were a focus on OA and assessment of more than one joint site. Two
coauthors (AEN and MWS) performed independent review of the identified abstracts, and
disagreements between reviewers were resolved by consensus. The full text articles were
then reviewed by two coauthors (AEN and YMG) to determine which would be carried
forward to data extraction. Exclusion criteria were 1) lack of a clear definition of OA (any of
radiographic, symptomatic, clinical, self-report) or 2) failure to report on more than one
distant joint site (multiple joints within one site, such as multiple hand joints, or tibiofemoral
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and patellofemoral alone, was not sufficient). Again, disagreements were resolved by
consensus. Additionally, one author (AEN) reviewed the bibliographies for all articles at the
full text review step and identified further relevant papers that were also included for data
extraction.
One author (AEN) performed data extraction using an Excel sheet containing categories
agreed upon by all authors. Extracted data included general study characteristics (first
author, publication year, study years, country, parent study, study type); OA-related
characteristics (type of OA assessment, joint sites assessed, criteria for OA diagnosis, risk
factors and outcomes considered); population characteristics (number of participants, age
range, % female, race/ethnic groups considered, and body mass index); and results (joint
sites affected, associations between joints, definitions of GOA, risk factors associated with
GOA, and outcomes assessed in GOA). Given the descriptive nature of this review, which
spans many years and various study types and does not focus on trials of interventions, no
assessment of study quality or risk of bias was performed. Similarly, due to the variety of




After removal of duplicates, the Medline search resulted in a total of 948 citations (855 on
March 23, 2011 [Table 1] and an additional 93 on September 25, 2012 using an identical
search strategy). An additional 28 citations were identified through hand searching of
bibliographies. Of 976 total articles, 840 were excluded based on title and abstract review,
leaving 136 for full-text review. Thirty-eight articles were excluded at this step (agreement
was 85%, others were adjudicated) due to either lack of a clear definition of OA or failure to
assess more than one joint site, leaving 98 articles for data extraction (Figure 1).
In the 98 included articles, 24 unique large cohorts were represented (total n=30,223), along
with numerous clinical series (total n=9252), across 22 countries, spanning five continents
(North America, Europe, Africa, Asia, and Australia), and 60 years (1952–2012, Table 2).
Joint sites
The joint sites assessed varied widely but most often included the hands and knees.
Radiographic and/or clinical definitions of OA were most often cited, although the
radiographic scales varied (Kellgren Lawrence grades were most often used), as did the
clinical definitions (the American College of Rheumatology definitions (5–7) were most
commonly cited). In some reports, only clinically abnormal or reportedly symptomatic joints
underwent radiography, while in others a specified set of joints was examined in all
participants. In 30 studies where a definition of GOA was clearly stated, no less than 15
definitions of GOA were given (Table 3). The interphalangeal joints of the hands were
essentially always included in GOA definitions, but there appeared to be little agreement as
to the appropriateness or necessity of including other joints such as the hip, spine, and feet.
Among the 18 studies from the Table explicitly stating which joints were considered, 100%
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included the hands, 16/18 included knees, 12/18 included hips, and 7/18 assessed spine (any
level) or feet.
Other studies assessed multiple joint sites but did not propose a GOA definition. Several of
these were supportive of GOA as a construct (supporting the constitutional/systemic nature
of OA)(8–16), while others were skeptical(17) or found little support for such a
construct(18). It is very difficult and potentially misleading to assess prevalence of GOA
given the variability of definitions, joint sites and populations (varied by setting, gender,
age, race, etc.) assessed. Reported estimates of the frequency of such variably defined GOA
ranged from 1–80%, although in most that were not selected for OA status, estimates were
in the 5–25% range.
Associated factors
Studies were focused primarily on the patterns of OA involvement, although a variety of risk
factors and outcomes were considered in the literature. Most studies were in Caucasian
populations, but a few assessed racial differences. Nodal changes and hip OA were
infrequent among African descent populations compared with British (19–21). Chinese
individuals had a similar frequency of DIP involvement compared to British, but had a low
frequency of OA at other joint sites(8). African American women compared with Caucasian
women had a higher frequency of MCP and knee OA and their combination (22). In another
study, African American men and women were less likely than Caucasians to have hand
OA, but more likely to have knee OA(16). That multiple joint OA is more common in
women compared with men was confirmed in several studies (4, 16, 23–28).
Increased frequency of GOA or higher risk of GOA progression was associated with age in
nearly all studies. Evidence of genetic/familial risk factors was reported (29–36). Some
studies reported associations between elevated body mass index and other measures of body
mass and multiple joint OA(22, 37, 38), but this finding was not consistent(39, 40). A higher
bone mineral density was seen in GOA patients in some series(41), but this association was
either equivocal(42, 43), or not seen in other work(44). One study estimated the heritability
of GOA at 42%(30). Smoking was noted to be possibly protective for GOA(45–47), but
again was not consistently seen across studies(22). Increased OA burden was associated
with poorer function and quality of life and increased disability(10, 26, 28, 48, 49).
At least 8 studies from 6 research groups used a summed score to capture OA at multiple
sites, generally to allow correlations with systemic markers such as bone mass, cytokines,
OA biomarkers or genetic markers. These included summed radiographic grades(44, 50) and
sums of numbers of affected joints or joint groups(30, 36, 45, 51–53). Cerhan, et al, reported
associations between the number of joints with OA, number of joint groups with OA, and a
binary definition of GOA (3 or more joints with K–L grade of 2 or higher) and survival
time(51). Joint counts correlated with levels of putative OA biomarkers including urinary
type II collagen C-telopeptide (uCTX-II)(52), cartilage oligomeric matrix protein (COMP)
(54, 55), YKL 40 (human cartilage glycoprotein 39)(56), matrix metalloproteinase-3
(MMP3)(57), and hyaluronic acid(58) but not with inflammatory markers such as
adiponectin, c-reactive protein, or tumor necrosis factor(53, 58).
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This systematic review provides the first comprehensive summary of the literature to date
assessing multiple joint involvement in OA. A detailed search with many synonyms was
performed given the lack of standardized terminology in this area. Our hope is that this work
will serve as a reference, in order to inform future studies, with the goal of encouraging
more research in this area. It seems clear from the results above that a higher burden of OA
is associated with poorer outcomes, with the suggestion that multiple joint OA may be a
marker of more severe disease that may show increased progression. It is also possible that
those with multiple joint OA may benefit more from systemic therapies than would those
with single joint/localized OA. However, it is also clear that there is a lack of not only a
clear consensus definition for research, but also of a widely understood clinical construct for
GOA.
Generally, two groups of similar, although not entirely consistent, definitions emerged: 1)
multiple hand joint OA, and 2) hand with large joint OA. Multiple hand joint OA, which
was reported mostly in descriptive papers, was defined as 3 or more hand joints, or 3 or
more specifically IP joints, with or without Heberden nodes, and in some definitions,
bilateral distribution was required. Hand with large joint (knee and/or hip) OA usually
included DIP or CMC joints with knee or hip joints. In the first group (multiple hand joints),
Doherty et al describe greater frequency and severity of radiographic and symptomatic knee
OA in patients 19 years or more after unilateral meniscectomy among patients with
concomitant polyarticular hand OA versus those without, independent of sex and age, and
for both operated and unoperated knees (24). Another group assessed nodal GOA (nodes +
at least 3 IP joints) in comparison with large joint OA (hip or knee) or controls and found
more frequent immunoglobulin (Ig) G rheumatoid factor positivity among nodal GOA
(51%) versus large joint OA (17%) or controls (11%, p<0.0001), with no differences for IgA
or IgM rheumatoid factor positivity (59). Nodal GOA patients more frequently had low IgA
levels (23%) compared to those with large joint OA (14%) or controls (6%) (59).
Associations have also been reported between multiple joint hand GOA and estrogen
receptor genotype (31) and elevated MMP-3 levels (57).
The second group, utilizing a definition of GOA that includes hand and large joint OA,
includes several studies from the Ulm and GARP cohorts. The Ulm study included
individuals scheduled for unilateral hip (n=420) or knee (n=389) joint replacement, and
defined GOA as OA involvement in at least 1 CMC joint, at least 2 IP joints (DIP or PIP) in
addition to the involved hip or knee (27). Eighty-two percent of hip and 87% of knee
patients had involvement of the contralateral joint, and 27% had GOA. GOA was more
frequent in knee OA patients (35%) compared with hip OA patients (19%) but the
prevalence was similar in these two groups after accounting for age and sex variation. GOA
was about twice as common in women compared to men, and was more frequent with
increasing age (27). Other analyses using this cohort have found that overweight (27%) or
obese (29%) individuals were more likely to have GOA compared with normal weight
(24%, although not statistically significant) (39); those in the highest tertile of serum uric
acid were more likely to have GOA in the hip group (adjusted OR [aOR] 3.5, 95% CI [1.3–
9.1]) but not in the knee group (aOR 1.2, 95% CI [0.6–2.4]) (60); and among women, those
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status post hysterectomy were less likely to have GOA (aOR 0.6 [95% CI 0.34–0.99]), again
more markedly in the hip group (aOR 0.34, 95% CI [0.12–0.97]) versus the knee group
(aOR 0.63, 95% CI [0.32–1.23]) (61). Other groups using a similar definition have found a
possible protective effect of smoking for GOA (46) and no association with vitamin D
receptor phenotype (62). Interestingly, in a post-mortem skeletal study, Waldron et al
defined GOA in the same way, but also found that all individuals meeting those criteria also
had shoulder OA (25).
The GARP study defined GOA as radiographic involvement of multiple hand joints or 2 of 4
total sites (of hands, cervical or lumbar spine, knee, and hip) with at least one symptomatic
site. GOA was positively associated with being married versus unmarried (aOR 2.0, 95% CI
[1.3–3.3]), having had menopause before age 45 years versus age 45–52 years (aOR 2.6,
95% CI [1.5–4.5]), with hysterectomy and ovariectomy (aOR 1.5–1.8), and with overweight
and obesity (aOR 1.9–2.1) (47). GOA was negatively associated with smoking (aOR 0.7,
95% CI [0.4–1.0]) and was less prevalent in those over 180cm versus under 160cm in height
(47). Physically demanding jobs were associated with GOA among men only (for men aOR
2.5 95% CI [1.2–5.3]; for women aOR 1.3, 95% CI [0.6–2.8]) (47). Each of the joint areas
studied in GARP, with the exception of disc degeneration, contributed to higher levels of
uCTX-II, and a significant association was found between uCTX-II levels and a composite
summed score of radiographic OA at multiple sites (estimate 0.06, 95% CI [0.04–0.07])
(52). Kornaat et al used data from the first 42 GARP patients along with 27 age and sex
matched controls and found that GOA patients had higher popliteal vessel wall thickness
compared to controls, suggesting an association between GOA and the metabolic syndrome
(63). Min et al used data from GARP and a similar GOA definition in the Rotterdam study
to assess genetic associations with the frizzled-related protein gene (part of the Wnt
pathway), finding that the G allele of the R324G variant was more common in GOA in both
populations (aOR 1.4 to 1.6) (33).
Overall, the studies included in this review have several limitations as a group, including
vague definitions of GOA or related constructs. It was often unclear exactly which joints or
joint groups were considered in a given study, and whether these were the same for all
participants; some studies assessed only symptomatic joints which varied among
individuals. Variation in assessed joints across studies, even when specified, makes
comparison of risk factors and outcomes difficult. In some cases, misclassification bias due
to differential assessment in cases and controls was a concern. Several studies were of
radiographic OA alone, without consideration of symptomatic or clinical factors. Study
participants were often recruited based on pain in a signal joint, such that the generalizability
to other groups or the general population was uncertain.
The strengths of this systematic review include our use of a professional research librarian,
adherence to the PRISMA guidelines, and dual independent reviews of both abstracts and
full text articles with adjudication. We were admittedly limited by the lack of appropriate
medical subject heading (MeSH) terms and the disparate terminology in the literature on this
topic, and in part because of this we were unable to perform any statistical or meta-analysis.
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Future research should focus on defining phenotypes of multiple joint involvement of OA to
determine if more homogeneous groups may exist. Such phenotypes, if identified, could be
used as outcomes for studies of systemic risk factors such as genetics and biomarkers, and
possibly in clinical trials particularly of systemic therapies. Focused trials in well-defined
subgroups thought to be at higher risk for incidence or progression of OA could result in
shorter, less expensive trials of promising OA treatments (both pharmacologic and non-
pharmacologic). It will also be important for future trials in OA to account for symptoms in
multiple joints, even if a signal joint is the therapeutic focus, since benefit or harm could
potentially be observed at distant joint sites (e.g. the adverse events observed in shoulder,
ankle, and foot for patients enrolled in tanezumab studies for hip and knee OA (64)).
CONCLUSION
We feel, based on the lack of clear definitions identified in this study, that the term GOA
should be discarded in favor of more specific and understandable terms, such as multiple
joint or polyarticular OA, which must be accompanied in every case by an unambiguous
statement as to the joints considered and the construct being used. Further study is needed to
determine appropriate phenotypes for clinical and research use.
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Table 1
Search terms and limits with results from initial search*
Search Queries Result #
#1 Search "Joints"[Mesh] 156488
#2 Search "Osteoarthritis"[Mesh] 34719
#3 Search osteoarthritis 43289
#4 Search osteoarthrosis 261351
#9 Search coxarthrosis 10408
#10 Search gonarthrosis 776
#11 Search "degenerative joint disease" 1471
#12 Search #2 or #3 or #4 or #9 or #10 or #11 262009
Combining terms for osteoarthritis and its synonyms
#13 Search generalized 75464
#14 Search polyarticular 1521
#15 Search global 147310
#16 Search nodal 26481
#17 Search “multiple joint” or “multi-joint” or “multi-site” 2276
#18 Search (hand* AND knee*) OR (hand* AND hip*) OR (knee* AND hip*) 17027
#19 Search #13 or #14 or #15 or #16 or #17 or #18 267668
Combining polyarticular with its synonyms to get at the concept of multiple joints
#20 Search #12 and #19 11385
The overlap—articles about polyarticular OA.
#21 Search #12 and #19 and #1 4186
#22 Search Gout[Mesh] 8695
#23 Search "Arthritis, Rheumatoid"[Mesh] 89074
#24 Search "Arthritis, Psoriatic"[Mesh] 2676
#25 Search #22 or #23 or #24 98762
#26 Search #21 NOT #25 3260
Removing references about inflammatory arthritis.
#27 Search #26 Limits: Humans, English 2391
Limiting to Human populations and English language articles.
#28 Search neuropathy OR neuropathies 53087
#29 Search skeletal muscle* OR "Muscle, Skeletal"[Mesh] 213567
#30 Search "Surgical Procedures, Operative"[Mesh] 2008342
#31 Search #28 or #29 or #30 2235850
#32 Search #27 NOT #31 1715
Removing unwanted subjects
#33 Search #32 Limits: All Adult: 19+ years 1210
Limiting to adults
#34 Search #33 Limits: Clinical Trial, Letter, Meta-Analysis, Randomized Controlled Trial, Review, Case Reports, Classical
Article, Clinical Conference, Clinical Trial, Phase I, Clinical Trial, Phase II, Clinical Trial, Phase III, Clinical Trial,
Phase IV, Comment, Comparative Study, Congresses, Consensus Development Conference, Consensus Development
Conference, NIH, Controlled Clinical Trial, Evaluation Studies, Guideline, Historical Article, Journal Article, Lectures,
Multicenter Study, Twin Study, Validation Studies
1209
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Search Queries Result #
#35 Search #34 Limits: Core clinical journals 307
Limiting to Core Clinical Journals – these were kept.
#38 Search Orthopaedic Journals (full listing available from authors) 228478
#39 Search #34 and #38 321
Limiting to the 115 Orthopedic journals. These were kept.
#40 Search Rheumatology Journals (full listing available from authors) 115904
#41 Search #34 and #40 516
Limiting to the 68 Rheumatology journals. These were kept.
#42 Search "Am J Epidemiol"[Journal] 10887
#43 Search #34 and #42 2
Limiting to Am J Epidemiol. These were kept.
#44 Search #35 or #39 or #41 or #43 855
Combining Core clinical, Orthopaedic journals, Rheumatology journals, and American Journal of Epidemiology
and removing duplicates.
*
Search was initially performed on March 23, 2011 (n=855 as shown in the table) and was updated on September 25, 2012 (identical search terms,
additional n=93 articles identified)
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Table 2
Summary of large cohorts represented in selected articles
# Cohort Country Reference(s)
1 Leigh and Wensleydale UK (4)
2 New Haven USA (23)
3 U.S. Health Examination Survey USA (65)
4 Spitalfields UK (25)
5 Bristol UK (26, 48)
6 Chingford UK (46, 66, 67)
7 Study of Osteoporotic Fractures USA (14)
8 Radium Dial Painters USA (45, 51)
9 Baltimore Longitudinal Study on Aging USA (68)
10 Ulm Germany (27, 39, 60, 61, 69)
11 Framingham USA (30, 53)
12 TwinsUK UK (70, 71)
13 Johnston County Osteoarthritis Project USA (15, 16, 54, 58, 72, 73)
14 Michigan Bone Health Study/Study of Women’s Health Across the Nation USA (22)
15 Rotterdam Netherlands (33, 74)
16 Clearwater Osteoarthritis Study USA (75)
17 Genetics, Arthrosis, and Progression Netherlands (33, 34, 36, 47, 52, 63, 76)
18 Genetics of Generalized Osteoarthritis USA (35)
19 Ullensaker Norway (28, 77)
20 Prediction of Osteoarthritis Progression USA (55)
21 Genetics of Osteoarthritis and Lifestyle UK (78)
22 Korean Longitudinal Study on Health and Aging South Korea (79)
23 Cohort Hip and Cohort Knee Netherlands (80)
24 Osteoarthritis Initiative USA (81)
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